Eva Hede Olsen

Eva Hede Olsen is a Postdoctoral Researcher at Aalborg University's Department of Health Science and Technology, Faculty of Medicine, specializing in neurobiology and drug delivery for blood-brain barrier therapeutics.

Educational background:

• PhD in Neuroscience/Pharmacology from Aalborg University (2024)

Her research centers on AAV-BR1 gene therapy for Niemann-Pick type C2 disease, focusing on endothelial and neuronal engagement to alleviate neurodegeneration and lipid accumulation. Key methodologies include viral vector engineering and preclinical modeling of blood-brain barrier transport.

Publications from 2023-2025 reveal progression from mechanistic studies (protein delivery strategies) to therapeutic validation (symptom alleviation in mouse models), demonstrating translational impact in neuropharmacology and rare disease treatment.

She actively collaborates within Aalborg University's Neurobiology Research and Drug Delivery group, investigating viral vector optimization for brain-targeted biotherapeutics.